Your browser is no longer supported. Please, upgrade your browser.
Settings
ACHV Achieve Life Sciences, Inc. daily Stock Chart
ACHV [NASD]
Achieve Life Sciences, Inc.
Index- P/E- EPS (ttm)-1.36 Insider Own1.13% Shs Outstand37.52M Perf Week9.05%
Market Cap19.45M Forward P/E- EPS next Y-0.22 Insider Trans0.00% Shs Float37.27M Perf Month-10.34%
Income-13.80M PEG- EPS next Q-0.12 Inst Own10.60% Short Float5.90% Perf Quarter28.21%
Sales- P/S- EPS this Y45.00% Inst Trans-7.81% Short Ratio1.83 Perf Half Y-26.81%
Book/sh0.48 P/B0.88 EPS next Y57.10% ROA-86.40% Target Price- Perf Year-77.61%
Cash/sh- P/C- EPS next 5Y- ROE-104.90% 52W Range0.23 - 2.51 Perf YTD-20.15%
Dividend- P/FCF- EPS past 5Y58.40% ROI- 52W High-83.14% Beta1.78
Dividend %- Quick Ratio8.40 Sales past 5Y- Gross Margin- 52W Low87.42% ATR0.03
Employees14 Current Ratio8.40 Sales Q/Q- Oper. Margin- RSI (14)52.46 Volatility7.99% 9.28%
OptionableNo Debt/Eq0.00 EPS Q/Q87.80% Profit Margin- Rel Volume5.46 Prev Close0.40
ShortableYes LT Debt/Eq0.00 EarningsMay 14 BMO Payout- Avg Volume1.20M Price0.42
Recom1.70 SMA200.94% SMA501.30% SMA200-40.16% Volume6,302,618 Change4.94%
Jun-30-20 09:33AM  
Jun-29-20 08:35AM  
08:30AM  
08:30AM  
Jun-05-20 02:49PM  
May-29-20 05:54AM  
May-14-20 07:30AM  
May-05-20 08:00AM  
Apr-30-20 04:50PM  
Apr-06-20 05:40AM  
Apr-02-20 08:00AM  
Mar-13-20 08:00AM  
08:00AM  
Mar-12-20 05:30AM  
Mar-03-20 05:30AM  
Feb-06-20 08:00AM  
Jan-13-20 06:30AM  
Dec-23-19 05:31AM  
Dec-19-19 04:05PM  
04:05PM  
Dec-17-19 01:06PM  
01:06PM  
Dec-09-19 05:30AM  
05:30AM  
Nov-11-19 10:00AM  
Nov-06-19 06:30AM  
06:30AM  
Oct-31-19 05:30AM  
Oct-24-19 07:11AM  
05:30AM  
05:30AM  
Sep-30-19 05:30AM  
Sep-25-19 06:30AM  
Sep-13-19 05:30AM  
Sep-09-19 10:34AM  
Sep-05-19 05:30AM  
Sep-04-19 05:30AM  
Aug-26-19 02:30PM  
10:30AM  
Aug-08-19 05:39PM  
04:05PM  
Jul-30-19 05:30AM  
05:30AM  
Jul-23-19 05:30AM  
Jul-10-19 10:47AM  
Jun-21-19 10:38AM  
05:30AM  
Jun-12-19 01:00PM  
Jun-11-19 07:00AM  
07:00AM  
Jun-03-19 04:05PM  
04:05PM  
May-30-19 02:00PM  
05:30AM  
May-15-19 04:05PM  
04:05PM  
May-07-19 05:30AM  
Apr-26-19 10:00AM  
Apr-24-19 05:30AM  
Apr-03-19 05:30AM  
Apr-02-19 07:30AM  
05:30AM  
Mar-25-19 10:00AM  
Mar-18-19 08:35AM  
05:30AM  
Mar-15-19 04:05PM  
Mar-14-19 04:05PM  
Mar-12-19 01:00PM  
Mar-05-19 05:30AM  
Feb-28-19 09:00AM  
Feb-25-19 10:30AM  
06:26AM  
Feb-22-19 10:40AM  
08:36AM  
05:30AM  
Feb-20-19 05:30AM  
Dec-28-18 07:06AM  
Dec-18-18 05:30AM  
Nov-29-18 08:06AM  
Nov-28-18 07:04AM  
Nov-07-18 04:05PM  
Oct-31-18 05:30AM  
Oct-30-18 09:45AM  
05:30AM  
Oct-03-18 12:41PM  
Oct-01-18 09:05AM  
Sep-27-18 08:56AM  
05:30AM  
Sep-26-18 05:30AM  
Sep-18-18 05:30AM  
Sep-06-18 05:30AM  
Sep-05-18 05:30AM  
Aug-08-18 04:05PM  
Aug-02-18 05:30AM  
Jul-12-18 08:00AM  
Jul-11-18 10:52AM  
05:30AM  
Jun-27-18 08:00AM  
Jun-26-18 11:41AM  
05:30AM  
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. Its product candidate include cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. The company has license agreements with Sopharma AD and University of Bristol; and a strategic collaboration with National Institutes of Health for the development of cytisinicline for smoking cessation. Achieve Life Sciences, Inc. was incorporated in 1991 and is based in Vancouver, Canada.